Advanced Search
MyIDEAS: Login to save this paper or follow this series

Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica

Contents:

Author Info

  • Gianluca Baio

    ()
    (Department of Statistical Sciences, University College London)

  • Laura Magazzini

    ()
    (Department of Economics, University of Verona)

  • Antonio Nicita

    ()
    (Department of Economics and Law, University La Sapienza Rome)

  • Fabio Pammolli

    ()
    (IMT Lucca Institute for Advanced Studies and CERM Foundation - Competitività, Regole, Mercati)

  • Massimo Riccaboni

    ()
    (IMT Lucca Institute for Advanced Studies and and Department of Managerial Economics, Strategy and Innovation, K.U. Leuven)

Abstract

Il presente rapporto analizza l'impatto del DL 15/04/2002 n. 63 del Governo Italiano ("Misure per il contenimento della spesa farmaceutica"), con particolare riferimento agli effetti indotti da tali misure sulle decisioni di investimento delle imprese, sulla struttura dell'industria di riferimento e sulle dinamiche di mercato che da tali misure possono discendere.

Download Info

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
File URL: http://www.cermlab.it/wp-content/uploads/cerm/wp/wpcerm-2003-00.pdf
File Function: First version, 2003
Download Restriction: no

Bibliographic Info

Paper provided by Competitività Regole Mecati (CERM) in its series Working Papers with number 0-2003.

as in new window
Length: 103 pages
Date of creation: Jan 2003
Date of revision:
Handle: RePEc:ern:wpaper:0-2003

Contact details of provider:
Postal: Via Fiorentina, 1, 53100 Siena
Phone: +39 3488120691
Email:
Web page: http://www.cermlab.it/
More information through EDIRC

Related research

Keywords: spesa farmaceutica; industria farmacuetica;

Find related papers by JEL classification:

References

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
as in new window
  1. Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000. "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper 15965, University Library of Munich, Germany.
  2. Berndt, Ernst R., 2000. "International comparisons of pharmaceutical prices: what do we know, and what does it mean?," Journal of Health Economics, Elsevier, vol. 19(2), pages 283-287, March.
  3. Danzon, Patricia M. & Chao, Li-Wei, 2000. "Cross-national price differences for pharmaceuticals: how large, and why?," Journal of Health Economics, Elsevier, vol. 19(2), pages 159-195, March.
  4. Matraves, Catherine, 1999. "Market Structure, R&D and Advertising in the Pharmaceutical Industry," Journal of Industrial Economics, Wiley Blackwell, vol. 47(2), pages 169-94, June.
  5. Dixit, Avinash K. & Pindyck, Robert S. & Sødal, Sigbjørn., 1997. "A markup interpretation of optimal rules for irreversible investment," Working papers WP 3945-97., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  6. Productivity Commission, 2001. "International pharmaceutical price differences," Others 0107004, EconWPA.
  7. Ernst R. Berndt & David M. Cutler & Richard Frank & Zvi Griliches & Joseph P. Newhouse & Jack E. Triplett, 2001. "Price Indexes for Medical Care Goods and Services -- An Overview of Measurement Issues," NBER Chapters, in: Medical Care Output and Productivity, pages 141-200 National Bureau of Economic Research, Inc.
  8. Giulio Bottazzi & Giovanni Dosi & Marco Lippi & Fabio Pammolli & Massimo Riccaboni, 2001. "Innovation and Corporate Growth in the Evolution of the Drug Industry," LEM Papers Series 2001/02, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  9. Laura Magazzini & Luigi Orsenigo & Fabio Pammolli, 2002. "The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis," Revue d'Économie Industrielle, Programme National Persée, vol. 99(1), pages 107-131.
  10. Stéphane Jacobzone, 2000. "Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals," OECD Labour Market and Social Policy Occasional Papers 40, OECD Publishing.
Full references (including those not matched with items on IDEAS)

Citations

Lists

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

Statistics

Access and download statistics

Corrections

When requesting a correction, please mention this item's handle: RePEc:ern:wpaper:0-2003. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ().

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.